Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001839970-24-000001
Filing Date
2024-01-02
Accepted
2024-01-02 08:15:12
Documents
1
Effectiveness Date
2024-01-02
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9826
  Complete submission text file 0001839970-24-000001.txt   10922
Mailing Address 6370 LUSK BLVD. STE. F205 SAN DIEGO CA 92121
Business Address 6370 LUSK BLVD. STE. F205 SAN DIEGO CA 92121 (650) 302-8388
BlossomHill Therapeutics, Inc. (Filer) CIK: 0001839970 (see all company filings)

EIN.: 851578711 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-501240 | Film No.: 24500353